Relationship between the clinical heterogeneity of neurocysticercosis and the immune-inflammatory profiles

Clinical Immunology

Volumn 116, Issue 3, 2005, Pages 271-278

  Chavarría, Anahí ^a   Fleury, Agnes ^b   García, Esperanza ^b   Márquez, Carlos ^b   Fragoso, Gladis ^a   Sciutto, Edda ^a  

^a INSTITUTO DE INVESTIGACIONES BIOMÉDICAS   (Mexico)

^b NATIONAL INSTITUTE OF NEUROLOGY AND NEUROSURGERY   (Mexico)

Author keywords

CNS; Immunological profiles; Inflammation; Neurocysticercosis; Taenia solium

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN G4; INTERLEUKIN 10; INTERLEUKIN 5; INTERLEUKIN 6;

ADOLESCENT; ADULT; AGED; ARTICLE; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID CYTOLOGY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE SEVERITY; EOSINOPHIL; FEMALE; HUMAN; IMMUNE RESPONSE; IMMUNOGLOBULIN BLOOD LEVEL; LEUKOCYTE COUNT; MALE; NERVOUS SYSTEM INFLAMMATION; NEUROCYSTICERCOSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN CEREBROSPINAL FLUID LEVEL; SEX DIFFERENCE; SUBARACHNOID SPACE; SYMPTOMATOLOGY; TAENIA SOLIUM;

ADOLESCENT; ADULT; AGED; ANTIBODIES, HELMINTH; BRAIN; FEMALE; HUMANS; IMMUNOGLOBULIN G; INFLAMMATION MEDIATORS; INTERLEUKIN-10; INTERLEUKIN-5; INTERLEUKIN-6; MALE; MIDDLE AGED; NEUROCYSTICERCOSIS; SEX CHARACTERISTICS; TAENIA SOLIUM;

EID: 23444448262     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clim.2005.04.008     Document Type: Article

References (30)

1. P.M. Knopf, C.J. Harling-Berg, H.F. Cserr, D. Basu, E.J. Sirulnick, S.C. Nolan, J.T. Park, G. Keir, E.J. Thompson, and W.F. Hickey Antigen-dependent intrathecal antibody synthesis in the normal rat brain: tissue entry and local retention of antigen-specific B cells J. Immunol. 161 1998 692 701
2. M. Oprica, C. Eriksson, and M. Schultzberg Inflammatory mechanisms associated with brain damage induced by kainic acid with special reference to the interleukin-1 system J. Cell. Mol. Med. 7 2003 127 140
3. V. Vázquez, and J. Sotelo The course of seizures after treatment for cerebral cysticercosis N. Engl. J. Med. 327 1992 696 701
4. J. Sotelo, V. Guerrero, and F. Rubio Neurocysticercosis: a new classification based on active and inactive forms. A study of 753 cases Arch. Intern. Med. 14 1985 442 445
5. M.T. Medina, E. Rosas, F. Rubio-Donnadieu, and J. Sotelo Neurocysticercosis as the main cause of late-onset epilepsy in Mexico Arch. Intern. Med. 150 1990 325 327
6. O.H. Del Brutto Prognostic factors for seizure recurrence after withdrawal of antiepileptic drugs in patients with neurocysticercosis Neurology 44 1994 1706 1709
7. J. Villagrán, and J.E. Olvera Cisticercosis humana: estudio clínico patológico de 481 casos de autopsia Patología 26 1988 149 156
8. A. Fleury, T. Gomez, I. Alvarez, D. Meza, M. Huerta, A. Chavarria, R.A. Carrillo Mezo, C. Lloyd, A. Dessein, P.M. Preux, M. Dumas, C. Larralde, E. Sciutto, and G. Fragoso High prevalence of calcified silent neurocysticercosis in a rural village of Mexico Neuroepidemiology 22 2003 139 145
9. A. Chavarria, B. Roger, G. Fragoso, G. Tapia, A. Fleury, M. Dumas, A. Dessein, C. Larralde, and E. Sciutto TH2 profile in asymptomatic Taenia solium human neurocysticercosis Microbes Infect. 5 2003 1109 1115
10. G. Fragoso, E. Lamoyi, A. Mellor, C. Lomeli, M. Hernandez, and E. Sciutto Increased resistance to Taenia crassiceps murine cysticercosis in Qa-2 transgenic mice Infect. Immun. 66 1998 760 764
11. E. Sciutto, G. Fragoso, M.L. Diaz, F. Valdez, R.M. Montoya, T. Govezensky, C. Lomeli, and C. Larralde Murine Taenia crassiceps cysticercosis: H-2 complex and sex influence on susceptibility Parasitol. Res. 77 1991 243 246
12. R. Vega, D. Pinero, B. Ramanankandrasana, M. Dumas, B. Bouteille, A. Fleury, E. Sciutto, C. Larralde, and G. Fragoso Population genetic structure of Taenia solium from Madagascar and Mexico: implications for clinical profile diversity and immunological technology Int. J. Parasitol. 33 2003 1479 1485
13. A. Fleury, A. Dessein, P.M. Preux, M. Dumas, G. Tapia, C. Larralde, and E. Sciutto Symptomatic human neurocysticercosis: age, sex and exposure factors relating with disease heterogeneity J. Neurol. 251 2004 830 837
14. O.H. Del Brutto, E. Garcia, O. Talamas, and J. Sotelo Sex-related severity of inflammation in parenchymal brain cysticercosis Arch. Intern. Med. 148 1988 544 546
15. E.C. Bueno, L. dos Ramos Machado, J.A. Livramento, and A.J. Vaz Cellular immune response of patients with neurocysticercosis (inflammatory and non-inflammatory phases) Acta Trop. 91 2004 205 213
16. E. Medina-Escutia, Z. Morales-Lopez, J.V. Proano, J. Vazquez, V. Bermudez, V.O. Navarrete, V. Madrid-Marina, J.P. Laclette, and D. Correa Cellular immune response and Th1/Th2 cytokines in human neurocysticercosis: lack of immune suppression J. Parasitol. 87 2001 587 590
17. E. Saliba, and A. Henrot Inflammatory mediators and neonatal brain damage Biol. Neonate 79 2001 224 227
18. K. Williams, N. Dooley, E. Ulvestad, B. Becher, and J.P. Antel IL-10 production by adult human derived microglial cells Neurochem. Int. 29 1996 55 64
19. A.S. MacDonald, P. Loke, R. Martynoga, I. Dransfield, and J.E. Allen Cytokine-dependent inflammatory cell recruitment patterns in the peritoneal cavity of mice exposed to the parasitic nematode Brugia malayi Med. Microbiol. Immunol. 192 2003 33 40
20. S.M. Pope, E.B. Brandt, A. Mishra, S.P. Hogan, N. Zimmermann, K.I. Matthaei, P.S. Foster, and M.E. Rothenberg IL-13 induces eosinophil recruitment into the lung by an IL-5- and eotaxin-dependent mechanism J. Allergy Clin. Immunol. 108 2001 594 601
21. O. Ghaffar, F. Lavigne, A. Kamil, P. Renzi, and Q. Hamid Interleukin-6 expression in chronic sinusitis: colocalization of gene transcripts to eosinophils, macrophages, T lymphocytes, and mast cells Otolaryngol.-Head Neck Surg. 118 1998 504 511
22. A.L. Taratuto, and S.M. Venturiello Trichinosis Brain Pathol. 7 1997 663 672
23. H. Sugaya, M. Aoki, T. Yoshida, K. Takatsu, and K. Yoshimura Eosinophilia and intracranial worm recovery in interleukin-5 transgenic and interleukin-5 receptor alpha chain-knockout mice infected with Angiostrongylus cantonensis Parasitol. Res. 83 1997 583 590
24. A. Foussat, F. Cottrez, V. Brun, N. Fournier, J.P. Breittmayer, and H. Groux A comparative study between T regulatory type 1 and CD4+CD25+ T cells in the control of inflammation J. Immunol. 171 2003 5018 5026
25. K.M. Myhr, K.S. Vagnes, T.H. Maroy, J.H. Aarseth, H.I. Nyland, and C.A. Vedeler Interleukin-10 promoter polymorphisms in patients with multiple sclerosis J. Neurol. Sci. 202 2002 93 97
26. M. Maurer, N. Kruse, R. Giess, K.V. Toyka, and P. Rieckmann Genetic variation at position -1082 of the interleukin 10 (IL10) promotor and the outcome of multiple sclerosis J. Neuroimmunol. 104 2000 98 100
27. B.A. De Jong, R.G. Westendorp, J. Eskdale, B.M. Uitdehaag, and T.W. Huizinga Frequency of functional interleukin-10 promoter polymorphism is different between relapse-onset and primary progressive multiple sclerosis Hum. Immunol. 63 2002 281 285
28. W. Hickey Basic principles of immunological surveillance of the normal central nervous system Glia 36 2001 118 124
29. L.B. Gordon, P.M. Knopf, and H.F. Cserr Ovalbumin is more immunogenic when introduced into brain or cerebrospinal fluid than into extracerebral sites J. Neuroimmunol. 40 1992 81 87
30. C. Harling-Berg, P.M. Knopf, J. Merriam, and H.F. Cserr Role of cervical lymph nodes in the systemic humoral immune response to human serum albumin microinfused into rat cerebrospinal fluid J. Neuroimmunol. 25 1989 185 193